Skip to main content
Fig. 1 | Cell & Bioscience

Fig. 1

From: SHMT2 regulates esophageal cancer cell progression and immune Escape by mediating m6A modification of c-myc

Fig. 1

SHMT2 expression and prognosis in EC. A: TCGA was applied to analyze SHMT2 expression in EC; B: RT-qPCR was employed to detect SHMT2 expression in normal and EC tissues; C: SHMT2 expression in different stages of EC patients; D: HPA database was conducted to validate SHMT2 expression in EC tissues and normal tissues; E: SHMT2 protein expression in EC tissues and paracancerous tissues was assayed by western blot; F: relationship between SHMT2 expression and prognosis was evaluated by Kaplan-Meier curve; G: SHMT2 mRNA expression in human normal esophageal epithelial cell lines and cancer cell lines; H: SHMT2 protein expression in human normal esophageal epithelial cell lines and cancer cell lines. *P < 0.05; **P < 0.01; ***P < 0.001

Back to article page